Technical Analysis for PRTK - Paratek Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 4.39 -2.23% -0.10
PRTK closed down 2.23 percent on Wednesday, September 18, 2019, on 84 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical PRTK trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Wide Bands Range Expansion -2.23%
Overbought Stochastic Strength -2.23%
Fell Below 200 DMA Bearish -14.59%
Slingshot Bullish Bullish Swing Setup -14.59%
Upper Bollinger Band Walk Strength -14.59%
Wide Bands Range Expansion -14.59%

Older signals for PRTK ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Paratek Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibiotics to save lives and alleviate suffering. It offers, omadacycline, a tetracycline-derived, broad-spectrum antibiotic for use as a first-line monotherapy for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other serious community-acquired bacterial infections. The company also provides WC 3035, a tetracycline-derived compound with dual narrow-spectrum antibacterial and potent anti-inflammatory activity for use in the treatment of acne and rosacea. In addition, it offers solutions for multiple sclerosis, SMS, and RA/IBD. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.
Medicine Biopharmaceutical Clinical Medicine Organ Systems Infection Multiple Sclerosis SMS Antibiotics Acne Antibiotic Hepatotoxins Skin And Skin Structure Infections Community Acquired Bacterial Pneumonia Rosacea Urinary Tract Infections Anti Acne Preparations Ibd
Is PRTK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.2
52 Week Low 2.87
Average Volume 440,819
200-Day Moving Average 5.1715
50-Day Moving Average 3.9104
20-Day Moving Average 4.2545
10-Day Moving Average 4.798
Average True Range 0.4261
ADX 27.6
+DI 30.3163
-DI 25.0918
Chandelier Exit (Long, 3 ATRs ) 4.6117
Chandelier Exit (Short, 3 ATRs ) 4.6383
Upper Bollinger Band 5.7125
Lower Bollinger Band 2.7965
Percent B (%b) 0.55
BandWidth 68.539194
MACD Line 0.3011
MACD Signal Line 0.2586
MACD Histogram 0.0425
Fundamentals Value
Market Cap 121.87 Million
Num Shares 27.8 Million
EPS -3.95
Price-to-Earnings (P/E) Ratio -1.11
Price-to-Sales 77.65
Price-to-Book 5.15
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.86
Resistance 3 (R3) 4.87 4.72 4.78
Resistance 2 (R2) 4.72 4.60 4.72 4.76
Resistance 1 (R1) 4.56 4.53 4.48 4.55 4.73
Pivot Point 4.41 4.41 4.37 4.40 4.41
Support 1 (S1) 4.24 4.28 4.17 4.23 4.05
Support 2 (S2) 4.09 4.21 4.09 4.02
Support 3 (S3) 3.93 4.09 4.00
Support 4 (S4) 3.92